These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 17203810)
21. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. Meier-Ewert HK; Ridker PM; Rifai N; Regan MM; Price NJ; Dinges DF; Mullington JM J Am Coll Cardiol; 2004 Feb; 43(4):678-83. PubMed ID: 14975482 [TBL] [Abstract][Full Text] [Related]
22. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention. Anderson JL Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868 [TBL] [Abstract][Full Text] [Related]
23. C-reactive protein: a nontraditional serum marker of cardiovascular risk. de Ferranti SD; Rifai N Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E; Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173 [TBL] [Abstract][Full Text] [Related]
25. [CRP--a marker of a pro-inflammatory state and cardiovascular risk]. Poledne R; Valenta Z; Pit'ha J Vnitr Lek; 2007 Apr; 53(4):391-5. PubMed ID: 17578172 [TBL] [Abstract][Full Text] [Related]
26. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002). Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376 [TBL] [Abstract][Full Text] [Related]
27. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk. Stewart RA Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039 [TBL] [Abstract][Full Text] [Related]
28. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732 [TBL] [Abstract][Full Text] [Related]
29. Determinants of C-reactive protein concentration in blood. de Maat MP; Kluft C Ital Heart J; 2001 Mar; 2(3):189-95. PubMed ID: 11305530 [TBL] [Abstract][Full Text] [Related]
30. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394 [TBL] [Abstract][Full Text] [Related]
31. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J; Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264 [TBL] [Abstract][Full Text] [Related]
32. C-reactive protein and atherosclerosis: quo vadis? Koenig W; Torzewski J Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861 [TBL] [Abstract][Full Text] [Related]
33. Serum C-reactive protein as a marker for wellness assessment. Kao PC; Shiesh SC; Wu TJ Ann Clin Lab Sci; 2006; 36(2):163-9. PubMed ID: 16682512 [TBL] [Abstract][Full Text] [Related]
34. [The revival of an old diagnostic marker: C-reactive protein]. Sela B Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859 [No Abstract] [Full Text] [Related]
35. [Markers of inflammatory process in stable and unstable coronary artery disease]. Okopień B; Basiak M; Madej A; Labuzek K; Belowski D; Haberka M; Herman ZS Pol Merkur Lekarski; 2006 Jul; 21(121):69-72. PubMed ID: 17007298 [TBL] [Abstract][Full Text] [Related]
36. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging. Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309 [TBL] [Abstract][Full Text] [Related]
37. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP. Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW; Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721 [TBL] [Abstract][Full Text] [Related]